Vyleesi · eligibility-specific offer
A manufacturer offer for a four-dose box, with the eligibility restriction kept beside the price. This is not a monthly subscription quote.
Inspect the terms, then compare
Sorting compares displayed numbers only. Billing units, routes, supply periods and included services can differ. Featured placements above are separate.
Advertised offer for eligible patients whose commercial insurance does not cover Vyleesi. Government-program beneficiaries are excluded from the assistance program. Free home delivery through BlinkRx; prescribing-visit cost is not established.
No matching offers. Try another filter.
Vyleesi is prescription bremelanotide for acquired, generalized hypoactive sexual desire disorder in premenopausal women meeting its criteria. It is not indicated for men, postmenopausal women or improving sexual performance. The label contraindicates use in uncontrolled hypertension or known cardiovascular disease. The $99 offer has eligibility restrictions and is not a universal cash price.
Follow the evidence
Checked October 8, 2026. Provider pages document advertised terms; they do not independently establish clinical outcomes.
Official public information; price and terms checked October 8, 2026.